BCRX BioCryst Pharmaceuticals, Inc. Future Profit
The stability of BioCryst (BCRX) is underpinned by robust developments in protein crystallography and oral molecules. The projected profit trend demonstrates business resilience, while 0.14 captures the magnitude of this parameter. Revenues are based on insurance payouts for the treatment of rare genetic pathologies. Operational efficiency is increasing through the outsourcing of logistics to specialized third-party operators.
Analytical breakdowns for BioCryst
- share price and consensus valuation forecast:
- market capitalization data:
- book capitalization information:
- company total debt and liquidity indicators:
- earnings and valuation multiples information:
BCRX - Company Net Income|Projected Future Earnings BioCryst|BCRX - Business Payback Period|Future Price to Earnings BioCryst Pharmaceuticals|BCRX - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple BioCryst|BCRX - Operating profit before deduction of amortization|Earnings per share for the last twelve months BioCryst|BCRX - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months biocryst.com|BCRX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year BioCryst
Basic company analysis:BCRX, BioCryst
BioCryst (BCRX) projected profit measures the expected net remaining funds after deducting all operating expenses and taxes, reflecting future capital generation efficiency. High margins for the angioedema treatment and patent protection through the end of the decade drive the upward trend in prospective net income, confirming the issuer's financial stability and the asset's growth potential.
Competing companies
ARGX (argenx SE) - Projected Future Earnings|Projected Future Earnings biontech.de|Future Profit ABVX (Abivax Corp)|ADMA (ADMA Biologics Inc) - Expected Net Income|Projected Future Earnings PTGX (Protagonist Therapeutics Inc)|Company Profit Forecast Immunovant Therapeutics (IMVT)|KNSA - Expected Profit|grifols.com (GRFS) - Future Profit|Adaptive Biotechnologies Corporation (ADPT) - Expected Profit|Future Profit Celldex Therapeutics Inc|Future Profit AUPH|Projected Future Earnings Vera Corp|Expected Profit Dianthus Therapeutics (DNTH)|pharvaris.com - Net Profit Forecast|Projected Future Earnings ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Expected Net Profit|Intrexon - Projected Future Earnings|PHAR: Expected Profit|NKTR: Projected Future Earnings|UPB - Company Profit Forecast|Expected Profit Zenas Biopharma|Expected Net Profit Immunome Inc IMNM|Projected Future Earnings GOSS|Future Profit KalVista Corp KALV|Expected Profit Septerna Inc SEPN|Expected Net Income PVLA|SVRA: Future Profit|Expected Net Profit Rigel Pharma|AnaptysBio Corp (ANAB) - Expected Profit|ATXS - Company Profit Forecast|Future Profit ENGN|RAPT (rapt.com) - Future Net Profit|Projected Future Earnings JBIO|Expected Profit ACRS (Aclaris Therapeutics Inc.)|Projected Future Earnings KYTX (Kyverna)|TLSA - Future Profit|CABA - Expected Profit|Expected Net Income VTYX (ventyxbio.com)|THTX (Theratechnologies) - Future Profit|Net Profit Forecast AVTX|Expected Profit Eledon|Agenus, Inc - Forward Earnings|Projected Future Earnings CLYM|ZURA (zurabio.com) - Expected Net Income|Projected Future Earnings ATYR (aTyr Pharma)|Projected Future Earnings Adagene Inc ADAG|IMA - Expected Profit|Expected Net Income STTK (Shattuck Labs, Inc.)|equilliumbio.com (EQ) - Expected Profit|Future Profit Connect Biopharma Holdings Limited|IMUX (Immunic Therapeutics) - Projected Future Earnings|Projected Future Earnings Atara Biotherapeutics Inc|Future Profit IFRX (InflaRx N.V.)|XFOR (X4 Pharmaceuticals, Inc) - Expected Net Income|Projected Future Earnings ACET (Adicet Bio, Inc.)|Company Profit Forecast Celularity Inc (CELU)|INMB - Expected Profit|Barinthus Biotherapeutics PLC (BRNS) - Future Profit|Kezar Life Sciences, Inc (KZR) - Expected Profit|Future Profit SAB Biotherapeutics Inc|Future Profit AKTX|Projected Future Earnings Enlivex Therapeutics, Ltd.|Expected Profit Q32 Bio Inc. (QTTB)|GeoVax Labs - Net Profit Forecast|Projected Future Earnings EDSA (Edesa)|iBio Corporation (IBIO) - Expected Net Profit|Carisma Tx - Projected Future Earnings|XTLB: Expected Profit|BOLT: Projected Future Earnings|HCWB - Company Profit Forecast|Expected Profit Aptevo Therapeutics, Inc.|Expected Net Profit aimimmuno.com AIM|Projected Future Earnings ADTX|Future Profit gribio.com GRI|Expected Profit XORTX Therapeutics XRTX|Expected Net Income HIND|REVB: Future Profit|Expected Net Profit Indaptus Corp|Scinai Immunotherapeutics (SCNI) - Expected Profit|CALI - Company Profit Forecast|Future Profit AFMD|ALLK (Allakos Therapeutics) - Future Net Profit|Projected Future Earnings HOOK|Expected Profit IGMS (igmbio.com)|Projected Future Earnings ITOS (iTeos Therapeutics)|OCEA - Future Profit|TCBP - Expected Profit|Expected Net Income THRD (Third Harmonic Bio Inc.)
